Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous ketamine for prevention of postpartum depression after cesarean delivery
ChiCTR-IPR-15007159Phase 4Recruiting
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in postpartum depression (PPD) (2 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: EPDS score. Started Oct 2015; status: recruiting.
02
Drugs
ketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR-IPR-15007159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007159.